Objectives: This study aimed to determine whether additional glycine can improve urine storage symptoms in outpatients. Methods: We recruited 50 outpatients (15 females, 35 males) with an Overactive Bladder Symptom Score (OABSS) of 3 or more. Participants being treated for urine storage disorders took additional glycine for 8 weeks at a dose of 3 g twice a day. Outcome measures included blood pressure, the International Prostate Symptom Score (IPSS), OABSS, Nocturia Quality of Life (N-QOL) score, urination frequency, sleep latency, time until the first void at night, bladder pain, improvement in urinary symptoms assessed with the Global Self-Assessment (GSA), and adverse events. Results: In the OABSS, the number of nighttime voids, urgency to urinate, urgent incontinence, and total score were improved. Improvements were also found in the IPSS total score for urine storage items, blood pressure, IPSS-QOL, time to first void, bladder pain, and GSA score, but no changes were seen in the frequency of urination at night, sleep latency or N-QOL score. No adverse events were recorded. Conclusion: Oral glycine improves objective and self-assessed urine storage symptoms, blood pressure, and bladder pain.
Yamadera, W., Inagawa, K., Chiba, S., Bannai, M., Takahashi, M. and Nakayama, K. (2007) Glycine Ingestion Improves Subjective Sleep Quality in Human Volunteers, Correlating with Polysomnographic Changes. Sleep and Biological Rhythms, 5, 126-131. https://doi.org/10.1111/j.1479-8425.2007.00262.x
Sugaya, K., Nishijima, S., Miyazato, M. and Ogawa, Y. (2005) Central Nervous Control of Micturition and Urine Storage. Journal of Smooth Muscle Research, 41, 117-132. https://doi.org/10.1540/jsmr.41.117
Nishijima, S., Sugaya, K., Miyazato, M., Ashitomi, K., Morozumi, M. and Ogawa, Y. (2003) Changes of Bladder Activity and Glycine Levels in the Spinal Cord and Serum after Spinal Cord Injury in Rats. Biomedical Research (Tokyo), 24, 165-171. https://doi.org/10.2220/biomedres.24.165
Al-Khrasani, M., Mohammadzadeh, A., Balogh, M., Király, K., Barsi, S., Hajnal, B., Köles, L., Zádori, Z.S. and Harsing, L.G.Jr. (2019) Glycine Transporter Inhibitors: A New Avenue for Managing Neuropathic Pain. Brain Research Bulletin, 152, 143-158. https://doi.org/10.1016/j.brainresbull.2019.07.008
Cioffi, C.L. (2018) Modulation of Glycine-Mediated Spinal Neurotransmission for the Treatment of Chronic Pain. Journal of Medical Chemistry, 61, 2652-2679. https://doi.org/10.1021/acs.jmedchem.7b00956
Nishijima, S., Sugaya, K., Fukuda, T., Miyazato, M., Ashimine, S. and Ogawa, Y. (2006) Serum Amino Acids as Indicators of Cerebrospinal Neuronal Activity in Patients with Micturition Disorders. International Journal of Urology, 13, 1479-1483. https://doi.org/10.1111/j.1442-2042.2006.01653.x
Nishijima, S., Sugaya, K., Miyazato, M., Ashitomi, K., Morozumi, M. and Ogawa, Y. (2003) Relationship between Bladder Activity and Amino Acid Levels in the Central Nervous System in Rats with Cerebral Infarction. Biomedical Research (Tokyo), 24, 173-180. https://doi.org/10.2220/biomedres.24.173
Miyazato, M., Sugaya, K., Nishijima, S., Ashitomi, K., Morozumi, M. and Ogawa, Y. (2005) Dietary Glycine Inhibits Bladder Activity in Normal Rats and Rats with Spinal Cord Injury. Journal of Urology, 173, 314-317. https://doi.org/10.1097/01.ju.0000141579.91638.a3
Miyazato, M., Sugaya, K., Nishijima, S., Kadekawa, K., Ashimine, S. and Ogawa, Y. (2005) Intrathecal or Dietary Glycine Inhibits Bladder and Urethral Activity in Rats with Spinal Cord Injury. Journal of Urology, 174, 2397-2400. https://doi.org/10.1097/01.ju.0000180415.69705.7a
Sugaya, K., Nishijima, S., Kadekawa, K., Noguchi, K., Ueda, T. and Yamamoto, H. (2019) Spinal Glycinergic and GABAergic Neurons Inhibit the Micturition Reflex after Electrical Stimulation of the Perineum in Rats with Pelvic Venous Congestion. International Journal of Urology, 26, 1149-1155. https://doi.org/10.1111/iju.14116
Sugaya, K., Oh-oka, H., Yamada, T., Miyata, M., Ashitomi, K., Kadekawa, K. and Nishijima, S. (2021) Dietary Glycine Improves Urine Storage Symptoms in Urology Outpatients. Journal of Complementary & Integrative Medicine, 18, 617-620. https://doi.org/10.1515/jcim-2020-0282
Homma, Y., Yoshida, M., Seki, N., Yokoyama, O., Kakizaki, H., Gotoh, M., Yamanishi, T., Yamaguchi, O., Takeda, M. and Nishizawa, O. (2006) Symptom Assessment Tool for Overactive Bladder Syndrome—Overactive Bladder Symptom Score. Urology, 68, 318-323. https://doi.org/10.1016/j.urology.2006.02.042
Barry, M.J., Fowler, F.J.Jr., O’Leary, M.P., Bruskewitz, R.C., Holtgrewe. H.L., Mebust, W.K. and Cockett, A.T. (1992) The American Urological Association Symptom Index for Benign Prostatic Hyperplasia. The Measurement Committee of the American Urological Association. Journal of Urology, 148, 1549-1557. https://doi.org/10.1016/S0022-5347(17)36966-5
Abraham, L., Hareendran, A., Mills, I.W., Martin, M.L., Abrams, P., Drake, M.J., MacDonagh, R.P. and Noble, J.G. (2004) Development and Validation of a Quality-of-Life Measure for Men with Nocturia. Urology, 63, 481-486. https://doi.org/10.1016/j.urology.2003.10.019
Kawai, N., Bannai, M., Seki, S., Koizumi, T., Shinkai, K., Nagao, K., Matsuzawa, D., Takahashi, M. and Shimizu, E. (2012) Pharmacokinetics and Cerebral Distribution of Glycine Administered to Rats. Amino Acids, 42, 2129-2137. https://doi.org/10.1007/s00726-011-0950-y
Yamada, S., Ito, Y., Nishijima, S., Kadekawa, K. and Sugaya, K. (2018) Basic and Clinical Aspects of Antimuscarinic Agents Used to Treat Overactive Bladder. Pharmacology & Therapeutics, 189, 130-148. https://doi.org/10.1016/j.pharmthera.2018.04.010
Hondo, M., Furutani, N., Yamasaki, M., Watanabe, M. and Sakurai, T. (2011) Orexin Neurons Receive Glycinergic Innervations. PLoS ONE, 6, e25076. https://doi.org/10.1371/journal.pone.0025076
Kawai, N., Sakai, N., Okuro, M., Karakawa, S., Tsuneyoshi, Y., Kawasaki, N., Takeda, T., Bannai, M. and Nishino, S. (2015) The Sleep-Promoting and Hypothermic Effects of Glycine Are Mediated by NMDA Receptors in the Suprachiasmatic Nucleus. Neuropsychopharmacology, 40, 1405-1416. https://doi.org/10.1038/npp.2014.326
Gao, H., Korim, W.S., Yao, S.T., Heesch, C.M. and Derbenev, A.V. (2019) Glycinergic Neurotransmission in the Rostral Ventrolateral Medulla Controls the Time Course of Baroreflex-Mediated Sympathoinhibition. Journal of Physiology, 597, 283-301. https://doi.org/10.1113/JP276467
Wang, Z., Zhang, J., Chen, L., Li, J., Zhang, H. and Guo, X. (2019) Glycine Suppresses AGE/RAGE Signaling Pathway and Subsequent Oxidative Stress by Restoring Glo1 Function in the Aorta of Diabetic Rats and in HUVECs. Oxidative Medicine and Cellular Longevity, 2019, Article ID: 4628962. https://doi.org/10.1155/2019/4628962
Rose, G.E., Denys, M.A., Kumps, C., Whishaw, D.M., Khan, F., Everaert, K.C. and Bower, W.F. (2019) Nocturnal Voiding Frequency Does Not Describe Nocturia-Related Bother. Neurourology and Urodynamics, 38, 1648-1656. https://doi.org/10.1002/nau.24029
Sugaya, K., Nishijima, S., Miyazato, M., Owan, T., Oshiro, Y., Uchida, A., Hokama, S. and Ogawa, Y. (2007) Investigation of Biochemical Factors Related to Non-Bothersome Nocturnal Urination. Biomedical Research (Tokyo), 28, 213-217. https://doi.org/10.2220/biomedres.28.213